Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOSAIC - A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate to Advanced Diabetic Kidney Disease

NCT04026165 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT04026165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04026165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOSAIC - A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate to Advanced Diabetic Kidney Disease
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 24, 2019
Completion date
September 3, 2021
Enrollment
384 (actual)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease